COMPOUND USED AS RET KINASE INHIBITOR AND APPLICATION THEREOF
The present invention belongs to the field of medical technology and specifically disclosed is a compound represented by formula (I'), or a pharmaceutically acceptable salt, stereoisomer, solvate or prodrug thereof, and each symbol therein is as defined in the claims. The compound of the presen...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
01.02.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention belongs to the field of medical technology and specifically disclosed is a compound represented by formula (I'), or a pharmaceutically acceptable salt, stereoisomer, solvate or prodrug thereof, and each symbol therein is as defined in the claims. The compound of the present invention may be used as a drug for regulating RET kinase activity or treating RET-related diseases, and has better pharmacokinetic properties. |
---|---|
Bibliography: | Application Number: EP20200810190 |